120 related articles for article (PubMed ID: 14703410)
1. [Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].
Chen CB; Pan JJ; Xu LY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2033-5. PubMed ID: 14703410
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Cai Y; Zhu GY; Xu B; Lü YY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2023-8. PubMed ID: 14703408
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up].
Han DM; Huang ZG; Zhang W; Yu ZK; Wang Q; Ni X; Chen XH; Pan JH; Wang H
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2029-32. PubMed ID: 14703409
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma].
Feng ZF; Pan HL; Song HS; Liu ZM; Huang Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):694-6. PubMed ID: 15201093
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
8. [Detection of p53 gene change and serum antibody level in phase II clinical trial of ad p53 gene therapy].
Zhao M; Xiao SW; Yang JX; Zhang SW; Lü YY
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3495-8. PubMed ID: 16686067
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma].
Huang GX; Zhao C; Han F; Zhang B; Qiu HJ; Xu BP; Chen XX; Hu PL
Ai Zheng; 2003 Oct; 22(10):1084-7. PubMed ID: 14558957
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a combination of rAd2p53 adenoviral gene therapy and radiotherapy in esophageal carcinoma.
Lu P; Yang X; Huang Y; Lu Z; Miao Z; Liang Q; Zhu Y; Fan Q
Cell Biochem Biophys; 2011 Apr; 59(3):147-52. PubMed ID: 21350839
[TBL] [Abstract][Full Text] [Related]
11. [Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus].
Xia ZJ; Chang JH; Zhang L; Jiang WQ; Guan ZZ; Liu JW; Zhang Y; Hu XH; Wu GH; Wang HQ; Chen ZC; Chen JC; Zhou QH; Lu JW; Fan QX; Huang JJ; Zheng X
Ai Zheng; 2004 Dec; 23(12):1666-70. PubMed ID: 15601557
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
[TBL] [Abstract][Full Text] [Related]
18. [Late course conformal radiotherapy combined with chemotherapy for stage III and IV a nasopharyngeal carcinoma].
Wu H; Lin Q; Yu ZH; Yang ZX; Feng LP
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1778-80. PubMed ID: 16253169
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
[TBL] [Abstract][Full Text] [Related]
20. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
